Angeles Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-375
| Closed | -$238K | – | 446 |
|
|
2025
Q1 | $238K | Buy |
375
+16
| +4% | +$10.1K | 0.02% | 257 |
|
|
2024
Q4 | $256K | Sell |
359
-2
| -0.6% | -$1.43K | 0.02% | 246 |
|
|
2024
Q3 | $379K | Buy |
361
+10
| +3% | +$10.5K | 0.03% | 164 |
|
|
2024
Q2 | $369K | Buy |
351
+26
| +8% | +$27.3K | 0.03% | 151 |
|
|
2024
Q1 | $313K | Buy |
325
+11
| +4% | +$10.6K | 0.03% | 165 |
|
|
2023
Q4 | $276K | Buy |
314
+2
| +0.6% | +$1.76K | 0.03% | 155 |
|
|
2023
Q3 | $257K | Buy |
312
+26
| +9% | +$21.4K | 0.04% | 145 |
|
|
2023
Q2 | $206K | Sell |
286
-1
| -0.3% | -$719 | 0.03% | 175 |
|
|
2023
Q1 | $236K | Buy |
+287
| New | +$236K | 0.04% | 158 |
|